MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood

V. D J, Y. H, R. T R, P. Anand Alladi (Bangalore, India)

Meeting: 2017 International Congress

Abstract Number: 577

Keywords: Development, Dopaminergic neurons, Substantia nigra pars compacta(SNpc)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Parkinson's Disease: Pathophysiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: Establish the developmental basis for varying nigral dopaminergic (DA) correlates in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) susceptible C57BL/6, MPTP resistant CD-1 and their resistant crossbred mice.

Background: Asian-Indians are less vulnerable to Parkinson’s disease (PD) than the Caucasians. Interestingly their admixed population is at much lesser risk. Studying this phenomenon through mice strains with differential MPTP susceptibility revealed variations in nigral DA neuronal number along with other cytomorphological features in assigning resistance/susceptibility.1,2

Methods: Postnatal day 2 (P2), P6, P10, P14, P18, P22 and adults of C57BL/6, CD-1 and their reciprocal crossbred mice were studied. Tyrosine hydroxylase (TH) immunostained midbrain sections were evaluated for nigral volume and DA neuronal number by planimetry and stereology, respectively. TH expression and the neuronal morphological development was examined, alongside overall nigral development.

Results: Nigral volume and DA numbers were lesser in C57BL/6 compared to CD-1 and the crossbreds at birth and remained so throughout the development. A significant increase in number and nigral volume was observed in all the strains till P14. However, a drastic fall was seen thereafter only in C57BL/6 before stabilising at adulthood. Interestingly, CD-1 and the crossbreds retained their numbers from P14 to stabilize with supernumerary DA neurons at adulthood. Neuronal size significantly increased from P2 to P10 and then attained their adult morphology in CD-1 and the crossbreds, whereas it continued to increase in C57BL/6, only to stabilize at P22. TH expression and nigra attained its adult architecture at P14 in CD-1 and the crossbreds, whereas at P22 in C57BL/6.

Conclusions: We provide the first unbiased stereological estimation of nigral DA number during postnatal development in mice. CD-1 and the crossbreds by birth acquire resilient cytomorphological features; evidenced by higher number of DA neurons at P2. Absence of neuronal loss in these strains after P14 as seen in C57BL/6 indicates lesser developmental cell death. Faster maturity of DA neurons and nigral architecture provide further evidence for superior developmental characteristics, which might render MPTP resistance at adulthood. This demonstrates that variable MPTP susceptibility and heterogeneity in PD pathogenesis may arise early during development.

References: 1. Vidyadhara DJ, Yarreiphang H, Raju TR, Alladi PA. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration. Molecular Neurobiology 2016 Oct 4. [Epub ahead of print]

2. Vidyadhara DJ, Yarreiphang H, Abhilash PL, Raju TR, Alladi PA. Differential expression of calbindin in nigral dopaminergic neurons in two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Journal of chemical neuroanatomy 2016 Oct;76(Pt B):82-89

To cite this abstract in AMA style:

V. D J, Y. H, R. T R, P. Anand Alladi. Admixing augments nigral dopaminergic correlates during development to impart resistance to MPTP-toxicity at adulthood [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/admixing-augments-nigral-dopaminergic-correlates-during-development-to-impart-resistance-to-mptp-toxicity-at-adulthood/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/admixing-augments-nigral-dopaminergic-correlates-during-development-to-impart-resistance-to-mptp-toxicity-at-adulthood/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley